IBIO: iBio Inc Company Value to Net Income
iBio, Inc. is recognized as a leading developer in the field of precision antibody matching for tumor combat, with the success of its systems relying on algorithmic accuracy and the pace of drug development. The price history of shares with the -1.50 indicator demonstrates the asset's market dynamics. The business scales through a digital environment, where revenue is generated from the sale of innovation licenses to major medical holdings.
%20P%2FE%20Multiple&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_IBIO_-_iBio-Inc._-_PE-Multiple "IBIO: iBio, Inc. Business Payback Period 07/04/2022 - 11/12/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns for iBio Corp (IBIO)
- price and consensus price forecast:
- market capitalization information:
- balance sheet net asset value indicators:
- debt and solvency information:
- earnings and market multiples details:
IBIO - Net Profit|Expected Profit iBio, Inc.|IBIO - P/E Multiple|Market Cap to Projected Earnings iBio Inc|IBIO - Price/Earnings to Growth Ratio|Company Value to EBITDA iBio, Inc.|IBIO - Operating profit before deduction of amortization|Earnings per share for the trailing year iBio|IBIO - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months ibioinc.com|IBIO - Earnings per share growth in current year|Projected earnings per share growth rate for next year iBio, Inc.
Comprehensive company analysis:ibioinc.com IBIO
Selecting high-quality issuers is based on comparing an asset's market value with its actual ability to generate profit. The price-to-earnings ratio, reflected through the company's forward P/E, measures the investment payback period, which is critical for iBio, Inc. (IBIO) when monetizing AI antibody developments and licensing fees from pharma partners, allowing for an assessment of whether the current quote is fair.
Key competitors
P/E Multiple argenx.com|Price to Earnings Ratio BNTX (BioNTech)|ABVX (ABIVAX) - Company Value to Net Income|P/E Multiple ADMA (ADMA Bio)|Business Payback Period Protagonist Corp (PTGX)|IMVT - Price to Earnings Ratio|kiniksa.com (KNSA) - Price to Earnings Ratio|Grifols (GRFS) - Price to Earnings Ratio|Price to Earnings Ratio Adaptive Biotech|Price to Earnings Ratio CLDX|P/E Multiple Aurinia Corp|Price to Earnings Ratio BioCryst (BCRX)|veratx.com - Price to Earnings Multiple|P/E Multiple DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Market Cap to Earnings|AbCellera Bio - P/E Multiple|Business Payback Period Tourmaline TRML|PGEN: P/E Multiple|PHAR (pharming.com) - Price to Earnings Ratio|NKTR (Nektar Therapeutics Inc.) - P/E Multiple|Upstream Bio, Inc. (UPB) - Business Payback Period|Price to Earnings Ratio Zenas Biopharma, Inc. (ZBIO)|IMNM - Market Cap to Earnings|Gossamer Bio, Inc. - Price to Earnings Ratio|Company Value to Net Income KALV|Septerna - P/E Multiple|Business Payback Period Pieris Pharma PVLA|Savara Corp (SVRA) - Price to Earnings Ratio|Price to Earnings Multiple RIGL|ANAB (AnaptysBio, Inc.) - P/E Multiple|Price to Earnings Ratio astriatx.com (ATXS)|Price to Earnings Ratio ENGN (enGene)|Business Payback Period RAPT Therapeutics Inc.|P/E Multiple JBIO (Aerovate Therapeutics)|Business Payback Period Aclaris Therapeutics, Inc (ACRS)|Kyverna Therapeutics - P/E Multiple|TLSA: Price to Earnings Ratio|CABA: P/E Multiple|VTYX - Business Payback Period|Price to Earnings Ratio Theratechnologies Inc|Market Cap to Earnings Avalo Therapeutics Inc AVTX|Price to Earnings Ratio Eledon Pharmaceuticals (ELDN)|AGEN: Market Cap to Net Income|P/E Multiple CLYM (Climb Bio)|Company Value to Net Income ZURA|aTyr - P/E Multiple|ADAG - P/E Multiple|ikenaoncology.com (IMA) - Price to Earnings Ratio|Shattuck Labs - Company Value to Net Income|Price to Earnings Ratio Equillium Inc|Price to Earnings Ratio Connect Pharma (CNTB)|P/E Multiple IMUX|P/E Multiple atarabio.com (ATRA)|InflaRx - Price to Earnings Ratio|Company Value to Net Income XFOR|Adicet - P/E Multiple|Business Payback Period Celularity Inc. CELU|INmune Bio Corp (INMB) - Price to Earnings Ratio|Price to Earnings Ratio Barinthus Biotherapeutics Corp|Price to Earnings Ratio Kezar Life Sciences|Price to Earnings Ratio sabbiotherapeutics.com (SABS)|Price to Earnings Ratio AKTX (Akari Therapeutics Plc)|P/E Multiple enlivex.com (ENLV)|Price to Earnings Ratio Q32 Bio QTTB|GOVX: Price to Earnings Multiple|Edesa Biotech, Inc. - P/E Multiple|Market Cap to Earnings Carisma Therapeutics|XTLB: P/E Multiple|BOLT - Business Payback Period|HCWB (HCW Biologics, Inc.) - P/E Multiple|Price to Earnings Ratio APVO|P/E Multiple AIM|Business Payback Period aditxt.com|Price to Earnings Ratio GRI Bio GRI|XORTX Therapeutics Inc (XRTX) - Market Cap to Earnings|HIND: Price to Earnings Ratio|Company Value to Net Income REVB (Revelation Biosciences Corp)|INDP: P/E Multiple|SCNI - Business Payback Period|Price to Earnings Ratio CalciMedica Inc|Price to Earnings Multiple AFMD (Affimed Therapeutics)|P/E Multiple ALLK|Price to Earnings Ratio hookipapharma.com HOOK|IGM Biosciences - Price to Earnings Ratio|Business Payback Period iteostherapeutics.com (ITOS)|Ocean Biomedical - P/E Multiple|Business Payback Period TC BioPharm (Holdings) Plc TCBP|THRD: P/E Multiple
